Stephen W. Webster
2016
In 2016, Stephen W. Webster earned a total compensation of $2.1M as Chief Financial Officer at Spark Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $215,000 |
|---|---|
| Salary | $401,346 |
| Stock Awards | $1,456,637 |
| Other | $38,642 |
| Total | $2,111,625 |
Webster received $1.5M in stock awards, accounting for 69% of the total pay in 2016.
Webster also received $215K in non-equity incentive plan, $401.3K in salary and $38.6K in other compensation.
Rankings
In 2016, Stephen W. Webster's compensation ranked 4,638th out of 14,075 executives tracked by ExecPay. In other words, Webster earned more than 67.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,638 out of 14,075 | 67th |
Division Manufacturing | 1,646 out of 5,486 | 70th |
Major group Chemicals And Allied Products | 512 out of 1,900 | 73rd |
Industry group Drugs | 378 out of 1,543 | 76th |
Industry Biological Products, Except Diagnostic Substances | 69 out of 287 | 76th |
Source: SEC filing on April 21, 2017.
Webster's colleagues
We found four more compensation records of executives who worked with Stephen W. Webster at Spark Therapeutics in 2016.